Where the Microbiome Industry Comes Together
"If being part of the Microbiome Therapeutics conversation is important to your research or business goals, this is the place to be." - List Labs
Our conference programme features the latest insights from the industry’s top companies and key thoughts-leaders, tackling the most pertinent issues and trends in the industry.
With three stages of content, you’ll be able to tailor your perfect agenda to meet your specific business needs – allowing you & your team to gain the tangible intel you need to fast-track your product development over the next 12 months.
2
full days of content
50+
speakers
250+
industry leading experts
8000
1-2-1 bookable meeting opportunities
With a full slate of main-stage keynotes, breakout sessions, networking and more, you and your team will gain the connections and insights you need across three key pillars.
Regulation
Gain tangible regulatory solutions to decrease the amount of time needed for new therapeutics to reach the market. With more FDA representatives presenting than any other microbiome therapeutics event, alongside leading regulatory consults, obtain the clarity you need to ensure your product meets its regulatory milestones.
Investment
If fundraising is your goal, Microbiome Connect is the place to be. We’ll have more investors in the room than ever before, all with one goal in mind: to evaluate microbiome investment prospects. Hear how to make your innovation stand out from the crowd and meet the right investor for your investment goals, whether you’re looking for early or late-stage investment.
Product Development
Deep dive into the most need-to-know data, technologies and strategies in drug discovery, clinical development and manufacturing across multiple therapeutic areas.
Maximize your ROI with our user-friendly 1-2-1 partnering platform, ensuring you meet the right people for your research & business needs.
TRAILBLAZING SPEAKERS
From every part of the microbiome industry, our expert speakers will take to the stage to share what’s happening now in the world of microbiome – and what’s going to happen next.
Nikole Kimes
Chief Executive Officer
Siolta Therapeutics
Cheri Ackerman
Co-Founder & CEO
Concerto Biosciences
Benjamin Hadida
Chief Executive Officer
Exeliom Biosciences
Mary Poor
Vice President of Quality and CMC
Siolta Therapeutics
Nik Sharma
Chief Executive Officer
BioCortex
Vivek Lal
Chief Scientific Officer
Alveolus Bio
Yongkyu Kim
CEO
BiomATZ
Tomas De Wouters
CEO
PharmaBiome
Matthew Cheng
CEO
KanvasBio
Travis Whitfill
COO
Azitra
Travis Whitfill is an Associate Research Scientist in the Department of Pediatrics. His background began in molecular biology and biochemistry, after receiving scientific training at the MD Anderson Cancer Center and Duke University. He is the co-founder of several additional startup companies, including a Connecticut-based microbiome company, Azitra Inc. He brings strong background in entrepreneurship and business, and is also a partner in a venture capital fund, Bios Partners, bringing experience in public markets, drug development, and venture capital investments.
His research interests are in pediatric emergency medicine and health policy and to improve pediatric acute care across the United States.
Christian Freguia
Vice President of Research
Rise Therapeutics
Jason Goldsmith
Senior Director, Medical, Translational, and Data Sciences
Nestle Health Science
Our Community of Biotechs
OUR PARTNERS
Platinum Partner
Cmbio
Website: https://clinical-microbiomics.com/
CosmosID® provides end-to-end solutions unlocking the microbiome. A provider of CLIA-certified & ICH-GCP compliant NGS Services and Bioinformatics Solutions, CosmosID offers a range of validated and optimized workflows for research and development.
CosmosID also offers independently validated, industry-leading pipelines for processing metagenomic data, yielding multi-kingdom, strain-level resolution with leading sensitivity and precision. Results can be accessed via CosmosID-HUB, a user-friendly and interactive software for comparative analysis of microbiome data, complete with dynamic charts, visualizations, and statistics.
Gold Partners
Biose Industrie
Website: https://www.biose.com/
Biose Industrie is a Contract Development and Manufacturing Organization (CDMO), specialised in Live Biotherapeutic Products. Founded in 1951, Biose Industrie has more than 65 years of experience in the development and production of live bacteria based drugs. Company offers lab development specialised in microbiology (anaerobic, aerobic, GMO strains) and is Drug GMP certified for the manufacturing of API (From 300L to 3 500L), clinical batches and commercial drug products (capsules in blisters or pills, sachets).
Boston Analytical
Website: https://www.basciences.com/
BA Sciences is a cGMP compliant, FDA/DEA registered, ISO/IEC-17025:2017 accredited world class pharmaceutical testing laboratory headquartered in Salem, NH. We provide identity, purity, and potency analyses necessary to characterize microbiome products and have a proven track record on a variety of Microbiome programs including Spore Fraction and Defined Drug Product manufacturing processes. BA Sciences also employs LabWare Inc.’s™ LIMS and ELN software to help ensure on-time and accurate results. Our testing services are provided to companies worldwide.
Nestle Health Sciences
Website: www.nestlehealthscience.us
Nestlé Health Science, a leader in the science of nutrition, is a globally managed business unit of Nestlé. We are committed to redefining the management of health, offering an extensive portfolio of science-based consumer health, medical nutrition, pharmaceutical therapies, and vitamin and supplement brands. Our extensive research network provides the foundation for products that empower healthier lives through nutrition. Headquartered in Switzerland, we have more than 12,000 employees around the world, with products available in more than 140 countries. For more information, please visit www.nestlehealthscience.us.
EXPERT'Biome
Website: https://lallemand-health-solutions.com/en/expertise-and-technologies/toll-manufacturing/
EXPERT'Biome, CDMO by Lallemand, is leveraging 90 years of know-how of Lallemand Health Solutions to support our partners in the development and production of their probiotics and LBP:
- Robust R&D expertise - a team of 40 people, 25+ on-going clinical trials, 430+ publications
- State-of-the-art GMP pharma production capabilities - 3 plants (France and Canada), from 480L to 20,000L
- An experienced regulatory team - 200+ approved food supplements, 40+ claims, 30+ API/Drugs
MTIG
Website: https://microbiometig.org/
The Microbiome Therapeutics Innovation Group (MTIG) is an independent 501(c)(6) coalition of companies leading the research and development of FDA-approved microbiome therapeutics and microbiome-based products to address unmet medical needs, improve clinical outcomes, and reduce health care costs.
Bac3Gel.com
Website: https://www.bac3gel.com/
WHO WE ARE
Bac3Gel is an innovation company that unblocks the full power of microbiota by providing the complexity of native ecosystems in a simple way.
WHAT WE DO
Ready to use In vitro models and Growth enhancer Beads.
Our technology is a tailorable system that provides the microbiota with the required conditions to thrive.
Available Standard Formulations for different districts:
Oral, Airway, Gastric, Intestinal, Cervicovaginal, and Universal.
OUR PRODUCTS
Ready to use In vitro models
That mimic mucus layers from different body districts, and can be used with traditional laboratory supplies. Its main advantages are:
- High throughput analysis
- Stand-alone solution
- Reduce R&D time
- Easy to use
- Include the main features of the human mucus
They all come in ready to use formats as extrudable gels in syringes, multiwell plates, transwell systems and modified to flow into microfluidic devices, compatible with standard wet lab experimental practices.
Growth enhancer Beads
For boosting proliferation of hard to grow microbiota In vitro. Its main advantages are:
- Compatible with bioreactors
- Easy to use
- Increases production yield
The formulation can be tailored to boost the growth of specific bacteria.
Procelys by Lesaffre
Website: https://procelys.com/
At Procelys by Lesaffre, we address biotech challenges in biopharma, food & feed, and renewable industries via fermentation by feeding living microorganisms. We advise, design, produce, and market solutions adapted to customers’ challenges. Everyday, on the five continents, together with our partners, we create value while empowering them with natural, innovation, and performing solutions. We are Biotech Partners.
List Biological Labs
Website: https://listlabs.com/
Need a Contract Development and Manufacturing partner that understands the unique needs of you Live Biotherapeutic? List Labs has over 45 years of experience and expertise in all aspects of bacterial development and manufacturing, including strict anaerobes and aerobes, injectables, even GMO’s and spore formers. Meet your timeline, quality requirements, and budget, with immediate pre-clinical and cGMP capacity.
WL Gore
Website: https://www.gore.com/products/industries/life-sciences/pharmaceutical-biopharmaceutical?xcmp=microbiome-connect-24_pharmbio_events_lyoguard_tradeshow_us%7c%7cshowsite
W. L. Gore & Associates is a global materials science company dedicated to transforming industries and improving lives. Since 1958, Gore has solved complex technical challenges in demanding environments — from outer space to the world’s highest peaks to the inner workings of the human body. With more than 12,000 Associates and a strong, team-oriented culture, Gore generates annual revenues of $4.5 billion.
Event Partners
Greenberg Traurig, LLP
Website: https://www.gtlaw.com/
Please visit our website for more information.Arome Science Inc
Website: https://www.arome-science.com/
Please visit our website for more information.Cellexus
Website: http://www.cellexus.com/
Cellexus International is revolutionising cell culture with our patented CellMakerTM single-use airlift bioreactors which help scientists to dramatically improve productivity whilst massively reducing the time & costs involved. The CellMaker allows for highly efficient, yet very gentle mixing, which is ideal for culturing a wide range of cell types. The CellMaker is a versatile, low footprint, bioreactor which combines simplicity and the efficiencies afforded by single use technologies to provide a readily scalable solution from 1.5 litres to 50 litres in an inherently GMP compliant system
Zymo Research
Website: https://www.zymoresearch.com/
Zymo Research is a globally established biotechnology company and industry leader in the fields of epigenetics, microbiomics and the emerging Next-Gen Sequencing space. With international facilities and a global distribution network, Zymo Research enables researchers in academia and the biomedical field to make cutting-edge discoveries all over the world. While the company provides some of the most technologically advanced products in the industry, everything is driven by the fundamental belief that "the beauty of science is to make things simple.
CKD Bio
Website: https://www.ckdbio.com/en/home
CKD Bio Corporation is devoted to serving the better life through better medicines, with over 70-years experience in the pharmaceutical industry. CKD Bio manufactures the highest quality intermediates and APIs through fully integrated manufacturing process from fermentation to chemical synthesis. CKD Bio is specialized in Contract Manufacturing and Contract Research in the field of fermentation
PARTNER WITH US
Based on your objectives, we can create bespoke packages designed specifically for you. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding, and Networking.
Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact [email protected]
Venue
Aloft Boston Seaport District Hotel, 401-403 D Street, Boston, Massachusetts, USA, 02210
Microbiome Connect invites you to join us at the Aloft Boston Seaport District Hotel, November 20-21.
For local hotels please click here.
ACADEMIC POSTER SHOWCASE
Are you looking to showcase your recent work to the Microbiome community?
Our dedicated poster session is the perfect way to get your research noticed by industry leaders and investors, ideal for PhD students or Post-Doctoral researchers. In order to present a poster, you must register as a delegate.
Please note that there is limited space available, and poster space is assigned on a first-come, first-served basis (subject to checks and successful registration). At the event, your presentation will be displayed in a dedicated poster area. The poster presentation session time of taking place is to be confirmed.
Posters should be a one page PDF in portrait orientation.
Abstracts received after this time may not be accepted so please submit your abstract as soon as possible! Academics that submit a poster abstract get a 10% discount
Posters should be sized A0 (841mm x 1189mm) in portrait orientation.
If you have any questions please contact [email protected] or submit your application below.
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.